^
    BIOMARKER:

    EGFR mutation + MET mutation

    i
    Other names: EGFR, ERBB, ERBB1, Epidermal growth factor receptor, DFNB97, AUTS9, RCCP2, C-Met, HGFR, HGF Receptor, Met Proto-Oncogene, HGF/SF Receptor, Proto-Oncogene C-Met, Scatter Factor Receptor, Tyrosine-Protein Kinase Met, Hepatocyte Growth Factor Receptor, MET, MET Proto-Oncogene, Receptor Tyrosine Kinase
    Entrez ID:
    1956; 4233
    Related biomarkers:
    Expression
    Mutation
    CNA
    Fusion
    Others

    Associations

    Heatmap
    News
    Twitter
    Trials
    EGFR mutation + MET mutation
    NSCLC
    osimertinib + savolitinib
    Sensitive: C3 – Early Trials
    ESMO 2021 - 4 weeks
    EGFR mutation + MET mutation
    NSCLC
    Tyrosine kinase inhibitor
    Sensitive: C3 – Early Trials